Russian clinical and cohort protocols
- Reported quantity
- 10 mg per administration
- Frequency
- Once daily
- Study duration
- 5–10 day courses, repeated once or twice yearly
The repeated short-course structure is consistent across this literature.

Protocols · Immune
Thymalin is a bovine thymic peptide extract used in Russia for decades in immune-modulation research, including long-running observational cohorts in older adults. It is a preparation rather than a defined compound.
Read this first
Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.
Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.
The repeated short-course structure is consistent across this literature.
T-lymphocyte subsets are the usual measured endpoint.
The same arithmetic for every vial size Thymalin is supplied in, using a fixed 3 ml of bacteriostatic water. One unit on a U-100 insulin syringe is 0.01 ml, so the unit column below is simply the volume that carries the reported amount. Educational arithmetic only — not instructions, and not medical advice.
Thymalin · 3 ml bacteriostatic water
| Vial size | Concentration | Per 1 unit |
|---|---|---|
| 10 mg | 3.33 mg/ml | 33 mcg |
| 100 mg | 33.33 mg/ml | 333 mcg |
No single reported amount applies to this compound, so only the concentration and the value of one unit are shown. Only the vial sizes this compound is actually supplied in are shown, and every figure assumes exactly 3 ml of bacteriostatic water. For any other volume, use the reconstitution calculator.
Supplied as a 10 mg lyophilised vial, reconstituted in 1–2 mL of sterile saline or bacteriostatic water in the source protocols.
Open the reconstitution calculatorThese are the published records the figures on this page are drawn from. Each one describes what researchers administered, in which model or population, and over what period. Quantities reported in a study are specific to that study's design and are not transferable guidance.
Khavinson VK · Neuro Endocrinol Lett · 2002 · PMID 14523363
Elderly patients received courses of thymic peptide bioregulator Thymalin (and pineal peptide Epithalamin) injections annually to assess effects on mortality and aging markers.
View the recordKuznik BI, Khavinson V, Shapovalov KG, et al. · Adv Gerontol · 2021 · DOI 10.1134/S2079057021040068
Older patients with severe COVID-19 received intramuscular Thymalin injections over a defined course to evaluate immune status regulation.
View the recordLinkova NS, Chalisova NI, Ivko OM, et al. · Biol Bull Rev · 2021 · DOI 10.1134/S2079086421040046
Review describing clinical dosing regimens (short intramuscular courses) of Thymalin used for immunocorrection in various patient populations.
View the recordPeptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.
Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.